Drug Shortage Report for BYSTOLIC
| Report ID | 240134 |
| Drug Identification Number | 02399008 |
| Brand name | BYSTOLIC |
| Common or Proper name | Bystolic |
| Company Name | ABBVIE CORPORATION |
| Market Status | MARKETED |
| Active Ingredient(s) | NEBIVOLOL |
| Strength(s) | 5MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 30 tablets |
| ATC code | C07AB |
| ATC description | BETA BLOCKING AGENTS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2024-11-18 |
| Actual start date | 2024-11-11 |
| Estimated end date | 2025-01-17 |
| Actual end date | 2025-01-16 |
| Shortage status | Resolved |
| Updated date | 2025-01-17 |
| Company comments | Please note that other strengths of Bystolic remain available for use in place of the Bystolic tablet 5mg |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 8401 TRANS-CANADA HIGHWAY SAINT-LAURENT, QUEBEC CANADA H4S 1Z1 |
| Company contact information | Should you require any additional information, please contact our Customer Service Department at 1-888-704-8270. |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v11 | 2025-01-17 | English | Compare |
| v10 | 2025-01-16 | French | Compare |
| v9 | 2025-01-16 | English | Compare |
| v8 | 2025-01-08 | French | Compare |
| v7 | 2025-01-08 | English | Compare |
| v6 | 2024-11-18 | French | Compare |
| v5 | 2024-11-18 | English | Compare |
| v4 | 2024-10-16 | French | Compare |
| v3 | 2024-10-16 | English | Compare |
| v2 | 2024-10-15 | French | Compare |
| v1 | 2024-10-15 | English | Compare |
Showing 1 to 11 of 11